521 related articles for article (PubMed ID: 19387482)
1. Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris.
Nakatsuji T; Kao MC; Fang JY; Zouboulis CC; Zhang L; Gallo RL; Huang CM
J Invest Dermatol; 2009 Oct; 129(10):2480-8. PubMed ID: 19387482
[TBL] [Abstract][Full Text] [Related]
2. Anti-bacterial and anti-inflammatory properties of capric acid against Propionibacterium acnes: a comparative study with lauric acid.
Huang WC; Tsai TH; Chuang LT; Li YY; Zouboulis CC; Tsai PJ
J Dermatol Sci; 2014 Mar; 73(3):232-40. PubMed ID: 24284257
[TBL] [Abstract][Full Text] [Related]
3. In vivo treatment of Propionibacterium acnes infection with liposomal lauric acids.
Pornpattananangkul D; Fu V; Thamphiwatana S; Zhang L; Chen M; Vecchio J; Gao W; Huang CM; Zhang L
Adv Healthc Mater; 2013 Oct; 2(10):1322-8. PubMed ID: 23495239
[TBL] [Abstract][Full Text] [Related]
4. Sebum free fatty acids enhance the innate immune defense of human sebocytes by upregulating beta-defensin-2 expression.
Nakatsuji T; Kao MC; Zhang L; Zouboulis CC; Gallo RL; Huang CM
J Invest Dermatol; 2010 Apr; 130(4):985-94. PubMed ID: 20032992
[TBL] [Abstract][Full Text] [Related]
5. A Precision Microbiome Approach Using Sucrose for Selective Augmentation of Staphylococcus epidermidis Fermentation against Propionibacterium acnes.
Wang Y; Kao MS; Yu J; Huang S; Marito S; Gallo RL; Huang CM
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834859
[TBL] [Abstract][Full Text] [Related]
6. Solid Lipid Nanoparticles Loaded with Retinoic Acid and Lauric Acid as an Alternative for Topical Treatment of Acne Vulgaris.
Silva EL; Carneiro G; De Araújo LA; Trindade Mde J; Yoshida MI; Oréfice RL; Farias Lde M; De Carvalho MA; Dos Santos SG; Goulart GA; Alves RJ; Ferreira LA
J Nanosci Nanotechnol; 2015 Jan; 15(1):792-9. PubMed ID: 26328443
[TBL] [Abstract][Full Text] [Related]
7. In-vitro investigation of anti-acne properties of Mangifera indica L. kernel extract and its mechanism of action against Propionibacterium acnes.
Poomanee W; Chaiyana W; Mueller M; Viernstein H; Khunkitti W; Leelapornpisid P
Anaerobe; 2018 Aug; 52():64-74. PubMed ID: 29906773
[TBL] [Abstract][Full Text] [Related]
8. The antimicrobial activity of liposomal lauric acids against Propionibacterium acnes.
Yang D; Pornpattananangkul D; Nakatsuji T; Chan M; Carson D; Huang CM; Zhang L
Biomaterials; 2009 Oct; 30(30):6035-40. PubMed ID: 19665786
[TBL] [Abstract][Full Text] [Related]
9.
Taleb MH; Abdeltawab NF; Shamma RN; Abdelgayed SS; Mohamed SS; Farag MA; Ramadan MA
Molecules; 2018 Aug; 23(9):. PubMed ID: 30154336
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial activity of long-chain polyunsaturated fatty acids against Propionibacterium acnes and Staphylococcus aureus.
Desbois AP; Lawlor KC
Mar Drugs; 2013 Nov; 11(11):4544-57. PubMed ID: 24232668
[TBL] [Abstract][Full Text] [Related]
11. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions.
Nishijima S; Kurokawa I; Katoh N; Watanabe K
J Dermatol; 2000 May; 27(5):318-23. PubMed ID: 10875198
[TBL] [Abstract][Full Text] [Related]
12. In vitro antimicrobial activity of benzoyl peroxide against Propionibacterium acnes assessed by a novel susceptibility testing method.
Okamoto K; Ikeda F; Kanayama S; Nakajima A; Matsumoto T; Ishii R; Umehara M; Gotoh N; Hayashi N; Iyoda T; Matsuzaki K; Matsumoto S; Kawashima M
J Infect Chemother; 2016 Jun; 22(6):426-9. PubMed ID: 26806150
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic resistant Cutibacterium acnes among acne patients in Jordan: a cross sectional study.
Alkhawaja E; Hammadi S; Abdelmalek M; Mahasneh N; Alkhawaja B; Abdelmalek SM
BMC Dermatol; 2020 Nov; 20(1):17. PubMed ID: 33203374
[TBL] [Abstract][Full Text] [Related]
14. Development and characterization of a novel antiacne niosomal gel of rosmarinic acid.
Budhiraja A; Dhingra G
Drug Deliv; 2015; 22(6):723-30. PubMed ID: 24786487
[TBL] [Abstract][Full Text] [Related]
15. Chemical characterization and bioactive potential of Thymus×citriodorus (Pers.) Schreb. preparations for anti-acne applications: Antimicrobial, anti-biofilm, anti-inflammatory and safety profiles.
Oliveira AS; Rolo J; Gaspar C; Cavaleiro C; Salgueiro L; Palmeira-de-Oliveira R; Ferraz C; Coelho S; Pastorinho MR; Sousa AC; Teixeira JP; Martinez-de-Oliveira J; Palmeira-de-Oliveira A
J Ethnopharmacol; 2022 Apr; 287():114935. PubMed ID: 34954264
[TBL] [Abstract][Full Text] [Related]
16. Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: implications of probiotics in acne vulgaris.
Wang Y; Kuo S; Shu M; Yu J; Huang S; Dai A; Two A; Gallo RL; Huang CM
Appl Microbiol Biotechnol; 2014 Jan; 98(1):411-24. PubMed ID: 24265031
[TBL] [Abstract][Full Text] [Related]
17. PEG-8 Laurate Fermentation of
Marito S; Keshari S; Huang CM
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32707723
[TBL] [Abstract][Full Text] [Related]
18. A Multifactorial Comparison of Ternary Combinations of Essential Oils in Topical Preparations to Current Antibiotic Prescription Therapies for the Control of Acne Vulgaris-Associated Bacteria.
Owen L; Grootveld M; Arroo R; Ruiz-Rodado V; Price P; Laird K
Phytother Res; 2017 Mar; 31(3):410-417. PubMed ID: 28124400
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of Propionibacterium acnes, Staphylococcus aureus and Staphylococcus epidermidis to 10 Kampo formulations.
Higaki S; Morimatsu S; Morohashi M; Yamagishi T; Hasegawa Y
J Int Med Res; 1997; 25(6):318-24. PubMed ID: 9427165
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial Activity of Pomegranate and Green Tea Extract on Propionibacterium Acnes, Propionibacterium Granulosum, Staphylococcus Aureus and Staphylococcus Epidermidis.
Li Z; Summanen PH; Downes J; Corbett K; Komoriya T; Henning SM; Kim J; Finegold SM
J Drugs Dermatol; 2015 Jun; 14(6):574-8. PubMed ID: 26091382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
